Edwards Lifesciences Corp (EW)
85.09
-0.16
(-0.19%)
USD |
NYSE |
May 06, 16:00
85.08
-0.01
(-0.01%)
Pre-Market: 20:00
Edwards Lifesciences Free Cash Flow: 251.20M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 251.20M |
December 31, 2023 | 629.50M |
September 30, 2023 | 788.20M |
June 30, 2023 | 682.00M |
March 31, 2023 | 972.30M |
December 31, 2022 | 953.40M |
September 30, 2022 | 1.040B |
June 30, 2022 | 1.261B |
March 31, 2022 | 1.428B |
December 31, 2021 | 1.402B |
September 30, 2021 | 1.409B |
June 30, 2021 | 1.050B |
March 31, 2021 | 716.60M |
December 31, 2020 | 647.00M |
September 30, 2020 | 692.10M |
June 30, 2020 | 940.50M |
March 31, 2020 | 1.087B |
December 31, 2019 | 904.50M |
September 30, 2019 | 808.40M |
June 30, 2019 | 704.40M |
March 31, 2019 | 522.40M |
December 31, 2018 | 685.00M |
September 30, 2018 | 754.30M |
June 30, 2018 | 772.00M |
March 31, 2018 | 820.60M |
Date | Value |
---|---|
December 31, 2017 | 825.20M |
September 30, 2017 | 658.50M |
June 30, 2017 | 541.20M |
March 31, 2017 | 517.30M |
December 31, 2016 | 487.00M |
September 30, 2016 | 411.60M |
June 30, 2016 | 430.50M |
March 31, 2016 | 470.10M |
December 31, 2015 | 443.20M |
September 30, 2015 | 428.60M |
June 30, 2015 | 246.20M |
March 31, 2015 | 856.50M |
December 31, 2014 | 928.60M |
September 30, 2014 | 970.80M |
June 30, 2014 | 1.086B |
March 31, 2014 | 422.90M |
December 31, 2013 | 362.60M |
September 30, 2013 | 343.10M |
June 30, 2013 | 339.10M |
March 31, 2013 | 359.10M |
December 31, 2012 | 246.10M |
September 30, 2012 | 237.50M |
June 30, 2012 | 227.80M |
March 31, 2012 | 174.50M |
December 31, 2011 | 223.90M |
Free Cash Flow Range, Past 5 Years
251.20M
Minimum
Mar 2024
1.428B
Maximum
Mar 2022
918.36M
Average
922.50M
Median
Free Cash Flow Benchmarks
Stryker Corp | 2.858B |
Align Technology Inc | 491.58M |
Abbott Laboratories | 4.923B |
Boston Scientific Corp | 1.553B |
Steris PLC | 593.99M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -53.50M |
Cash from Investing (Quarterly) | 63.10M |
Cash from Financing (Quarterly) | 61.70M |
Free Cash Flow Per Share (Quarterly) | -0.2298 |
Free Cash Flow to Equity (Quarterly) | -139.00M |
Free Cash Flow to Firm (Quarterly) | -138.80M |
Free Cash Flow Yield | 0.49% |